ERIN NAIL: Open Payments
NPI 1558750810 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 50 payments from 13 companies in 2025. Trend: 2023 $50 · 2024 $601 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $199 |
| Novo Nordisk Inc | 10 | $170 |
| GlaxoSmithKline, LLC. | 6 | $124 |
| Astellas Pharma US Inc | 5 | $109 |
| PFIZER INC. | 6 | $106 |
| Abbott Laboratories | 2 | $41 |
| Exact Sciences Corporation | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
Products named: Ozempic, Veozah, TRELEGY ELLIPTA, MOUNJARO, PREVNAR 20, JARDIANCE, FREESTYLE LIBRE 3, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
